ALLMedicine™ Acalculous Cholecystitis Center

Mar 7th, 2023 - History and Physical Examination C belli infection is most commonly observed in immunocompromised individuals or in individuals who have recently traveled to tropical areas, in people who are institutionalized, or in persons who live in poor sanit...

Jan 28th, 2023 - ACUTE ACALCULOUS CHOLECYSTITIS TRIGGERED BY AN ACUTE FLARE-UP IN VIRAL HEPATITIS B INFECTION: A CASE REPORT.|2023|Öcal S,Eren Durmuş M,Yalçın İŞ,Alparslan AŞ,Çekin AH,|diagnosis,etiology,complications,diagnosis,

Nov 30th, 2022 - Relatively recently, the concept that immunoglobulin G4 (IgG4)-related disease is a distinct chronic inflammatory disorder rather than a subset of Sjögren's syndrome has been accepted. IgG4-related disease (IgG4-RD) is a fibro-inflammatory systemi...

Nov 8th, 2022 - The introduction of percutaneous cholecystostomy (PCT) has shifted the paradigm in treatment of acute calculous and acalculous cholecystitis. PCT has high success and low complication rates, but there are still unresolved issues regarding the dura...

Sep 13th, 2022 - Acute acalculous cholecystitis (AAC) is characterized by acute onset, rapid progression, high mortality, and various complications. Cyclophilin D (CypD) regulates the mitochondrial permeability transition pore (MPTP) and is involved in the occurre...

May 6th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

Apr 1st, 2022 - Acute cholecystitis (AC) is defined as an acute inflammatory disease of the gallbladder consequently to the presence of sludge or stones. AC accounts for 3-10% of all cases of abdominal pain. Cholecystolithiasis accounts for 90-95% of all causes o...

Nov 26th, 2021 - Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments, the complication rate of ACC is 8-20%, and the mortality rate is 0.5-6% in recent series. The Tokyo Guidelines (TG) advocate for different...

Jul 15th, 2021 - Extracorporeal membrane oxygenation is an important method for the management of severe refractory heart and lung dysfunction, and improvements in extracorporeal membrane oxygenation equipment and increased experience have made it possible to use ...

Feb 9th, 2021 - Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments, the complication rate of ACC is 20-55%, and the mortality rate is 0.5-15% in recent series. The Tokyo Guidelines (TG) advocate for differe...

Mar 30th, 2015 - Gallbladder disease continues to be a major healthcare problem in the United States with more than 750,000 cholecystectomies being performed each year. In the last decade, the proportion of elective cholecystectomies performed for chronic acalculo...

Jun 9th, 2020 - Children and adolescents with COVID-19 who developed multisystem inflammatory syndrome (MIS-C) often exhibited marked gastrointestinal (GI) manifestations, sometimes confounding diagnosis by mimicking GI infections or inflammatory bowel disease (I...

Apr 12th, 2018 - Several new and potentially life-threatening adverse events associated with the use of alemtuzumab (Lemtrada, Genzyme) in multiple sclerosis (MS) have been reported. Three separate papers published online in Neurology on March 30 describe eight ca...

Apr 11th, 2018 - Rare but serious adverse events associated with alemtuzumab treatment of multiple sclerosis (MS) have recently been revealed by postmarketing surveillance, according to three new case reports and series in Neurology. The complications include acut.

Apr 11th, 2018 - Rare but serious adverse events associated with alemtuzumab treatment of multiple sclerosis (MS) have recently been revealed by postmarketing surveillance, according to three new case reports and series in Neurology. The complications include acut.

Apr 6th, 2018 - Action Points Note that several case reports document severe side effects associated with alemtuzumab use in patients with relapsing-remitting multiple sclerosis. Acute acalculous cholecystitis has been previously reported and now appears on the p...